Stay updated with breaking news from Outcomes Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF)
Health leaders have been reluctant to acknowledge the crisis, according to a report.
Ending violence against women and children
The new National Plan to End Violence Against Women and Children 2022-2032 includes provisions to track and monitor the prevalence of family, domestic and sexual violence to gauge its effectiveness.
Scoop Community provides New Zealand Community news and views